Showing 1831-1840 of 3223 results for "".
- FDA Finds 'Substantive' Issues in Aldeyra’s NDA for Reproxalap for Dry Eye Diseasehttps://modernod.com/news/fda-finds-substantive-issues-in-aldeyras-reproxalap-drug-candidate-for-dry-eye-disease/2481895/Aldeyra Therapeutics was dealt a major setback this week as the FDA identified "substantive review issues" in the company’s new drug application for dry-eye disease treatment candidate reproxalap. In a US securities
- Alcon Showcases New TOTAL30 Multifocal Lenses and Other Innovations at #Academy23https://modernod.com/news/alcon-demonstrates-commitment-to-innovation-at-academy23-showcasing-total30-multifocal/2481884/Alcon will introduce TOTAL30 Multifocal, the first and only reusable Water Gradient multifocal contact lens, along with the latest advancements in eye care technology at the American Academy of Optometry Annual Meeting (#Academy23) in New Orleans, October 11-14, 2023. Alcon&rs
- Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopiahttps://modernod.com/news/alcon-launches-total30-multifocal-contact-lenses-for-patients-with-presbyopia/2481879/Alcon announced the global launch of TOTAL30 Multifocal, the first and only monthly water gradient multifocal contact lens, according to Alcon. The lenses have begun to roll out in the United States and in select international markets. Many lens wearers stop wearing contact le
- Altris Receives FDA Clearance of Altris IMS Platform for OCT Scan Analysishttps://modernod.com/news/altris-receives-fda-clearance-of-altris-ims-platform-for-oct-scan-analysis/2481833/Altris received FDA 510(k) clearance for the Altris IMS, the company’s image, and data management platform. The Altris platform is designed to store, organize, and support in-depth analysis of Optical Coherence Tomography (OCT) scans. The platform provides secu
- NovaBay Pharmaceuticals’ Avenova Allograft is Launched in the United Stateshttps://modernod.com/news/novabay-pharmaceuticals-avenova-allograft-is-launched-in-the-united-states/2481830/NovaBay Pharmaceuticals announced the launch of the Avenova Allograft in the United States through its physician-dispensed channel. The company’s prescription optic allograft, which is intended for use as a protective covering during the repair of ocular surfaces, is manufactured using BioS
- NovaBay Pharmaceuticals Enters Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova Allografthttps://modernod.com/news/novabay-pharmaceuticals-enters-agreement-with-biostem-technologies-to-commercialize-amniotic-tissue-allograft-as-avenova-allograft/2481821/NovaBay Pharmaceuticals and BioStem Technologies announced an agreement under which NovaBay has been granted the right to commercialize BioStem Technologies’ Amniotic Tissue Allograft, which is intended for use as a protective covering during the repair of ocular surfaces. Fi
- Alcon: Cataract Surgery with AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependencehttps://modernod.com/news/alcon-cataract-surgery-with-acrysof-iq-vivity-iols-demonstrates-sustained-high-patient-satisfaction-and-reduced-spectacle-dependence/2481819/Alcon revealed final data from its Vivity Registry Study, which monitored real-world patient experiences for up to 12 months post-cataract surgery with implantation of either AcrySof IQ Vivity or AcrySof IQ Vivity Toric presbyopia-correcting intraocular lens (PCIOL). Data from
- Award-Winning Actress, Dancer and Director Debbie Allen Joins Prevent Blindness and Regeneron to Raise Awareness of Serious Retinal Diseaseshttps://modernod.com/news/award-winning-actress-dancer-and-director-debbie-allen-joins-prevent-blindness-and-regeneron-to-raise-awareness-of-serious-retinal-diseases/2481818/Award-winning actress, dancer and director Debbie Allen is partnering with Prevent Blindness and Regeneron to launch the 'Gr8 Eye Movement,' a new disease awareness campaign that aims to address gaps in how people understand the risk of developing certain serious retinal di
- Alcon to Showcase New Data and Innovation to Support Ophthalmic Surgical Teams at ESCRShttps://modernod.com/news/alcon-to-showcase-new-data-and-innovation-to-support-ophthalmic-surgical-teams-at-escrs/2481815/Alcon will present a lineup of scientific data at the 41st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) Sept. 8-12 in Vienna, Austria. Alcon will showcase product updates designed to deliver patient outcomes and operational efficiencies for ophthalmologists an
- Johnson & Johnson Vision Announces Launch of Elita Platform to Correct Myopia with New SILK Procedurehttps://modernod.com/news/johnson-johnson-vision-announces-launch-of-elita-platform-to-correct-myopia-with-new-silk-procedure/2481802/Johnson & Johnson Vision will launch the new Elita Platform at European Society of Cataract and Refractive Surgeons (ESCRS) Congress, September 8-12, 2023, in Vienna, Austria. The Elita Platform enables surgeons to perform refractive correction on patients w